nodes	percent_of_prediction	percent_of_DWPC	metapath
Moclobemide—MAOB—Alzheimer's disease	0.381	0.759	CbGaD
Moclobemide—CYP2D6—Alzheimer's disease	0.121	0.241	CbGaD
Moclobemide—CYP2D6—Rivastigmine—Alzheimer's disease	0.0716	0.244	CbGbCtD
Moclobemide—CYP2C19—Memantine—Alzheimer's disease	0.0653	0.222	CbGbCtD
Moclobemide—CYP2C9—Donepezil—Alzheimer's disease	0.0626	0.213	CbGbCtD
Moclobemide—CYP2D6—Donepezil—Alzheimer's disease	0.0572	0.195	CbGbCtD
Moclobemide—CYP2D6—Galantamine—Alzheimer's disease	0.0369	0.126	CbGbCtD
Moclobemide—MAOA—locus ceruleus—Alzheimer's disease	0.00424	0.378	CbGeAlD
Moclobemide—Nightmare—Galantamine—Alzheimer's disease	0.00113	0.00844	CcSEcCtD
Moclobemide—Metrorrhagia—Rivastigmine—Alzheimer's disease	0.00113	0.00842	CcSEcCtD
Moclobemide—Apathy—Rivastigmine—Alzheimer's disease	0.00113	0.00842	CcSEcCtD
Moclobemide—Flat affect—Rivastigmine—Alzheimer's disease	0.00112	0.00835	CcSEcCtD
Moclobemide—Dermatitis atopic—Rivastigmine—Alzheimer's disease	0.00109	0.00813	CcSEcCtD
Moclobemide—Gingivitis—Memantine—Alzheimer's disease	0.00105	0.00784	CcSEcCtD
Moclobemide—Aggression—Donepezil—Alzheimer's disease	0.00103	0.00771	CcSEcCtD
Moclobemide—Gingivitis—Rivastigmine—Alzheimer's disease	0.00103	0.00767	CcSEcCtD
Moclobemide—Extrasystoles—Memantine—Alzheimer's disease	0.000979	0.00731	CcSEcCtD
Moclobemide—Dysarthria—Donepezil—Alzheimer's disease	0.000959	0.00716	CcSEcCtD
Moclobemide—Extrasystoles—Rivastigmine—Alzheimer's disease	0.000958	0.00715	CcSEcCtD
Moclobemide—Aggression—Memantine—Alzheimer's disease	0.000937	0.007	CcSEcCtD
Moclobemide—Minaprine—ACHE—Alzheimer's disease	0.00093	0.226	CrCbGaD
Moclobemide—Aggression—Rivastigmine—Alzheimer's disease	0.000917	0.00685	CcSEcCtD
Moclobemide—Hepatic enzyme increased—Memantine—Alzheimer's disease	0.000871	0.0065	CcSEcCtD
Moclobemide—Dysarthria—Rivastigmine—Alzheimer's disease	0.000852	0.00636	CcSEcCtD
Moclobemide—Nightmare—Memantine—Alzheimer's disease	0.000795	0.00594	CcSEcCtD
Moclobemide—Nightmare—Rivastigmine—Alzheimer's disease	0.000778	0.00581	CcSEcCtD
Moclobemide—Gastritis—Galantamine—Alzheimer's disease	0.000752	0.00562	CcSEcCtD
Moclobemide—Urine output increased—Memantine—Alzheimer's disease	0.000745	0.00556	CcSEcCtD
Moclobemide—Urine output increased—Rivastigmine—Alzheimer's disease	0.000728	0.00544	CcSEcCtD
Moclobemide—Hot flush—Donepezil—Alzheimer's disease	0.000704	0.00526	CcSEcCtD
Moclobemide—Menopausal symptoms—Donepezil—Alzheimer's disease	0.000698	0.00521	CcSEcCtD
Moclobemide—MAOB—embryo—Alzheimer's disease	0.000696	0.0621	CbGeAlD
Moclobemide—Sleep disorder—Memantine—Alzheimer's disease	0.000691	0.00516	CcSEcCtD
Moclobemide—Polyuria—Memantine—Alzheimer's disease	0.000681	0.00509	CcSEcCtD
Moclobemide—Sleep disorder—Rivastigmine—Alzheimer's disease	0.000676	0.00505	CcSEcCtD
Moclobemide—Disorientation—Memantine—Alzheimer's disease	0.000668	0.00499	CcSEcCtD
Moclobemide—Polyuria—Rivastigmine—Alzheimer's disease	0.000666	0.00497	CcSEcCtD
Moclobemide—Osteoarthritis—Donepezil—Alzheimer's disease	0.000658	0.00492	CcSEcCtD
Moclobemide—Hot flush—Memantine—Alzheimer's disease	0.000639	0.00477	CcSEcCtD
Moclobemide—Menopausal symptoms—Memantine—Alzheimer's disease	0.000634	0.00473	CcSEcCtD
Moclobemide—Irritability—Donepezil—Alzheimer's disease	0.000628	0.00469	CcSEcCtD
Moclobemide—Hot flush—Rivastigmine—Alzheimer's disease	0.000625	0.00467	CcSEcCtD
Moclobemide—Menopausal symptoms—Rivastigmine—Alzheimer's disease	0.00062	0.00463	CcSEcCtD
Moclobemide—MAOB—forebrain—Alzheimer's disease	0.000615	0.0549	CbGeAlD
Moclobemide—Dry skin—Donepezil—Alzheimer's disease	0.000604	0.00451	CcSEcCtD
Moclobemide—Bradycardia—Galantamine—Alzheimer's disease	0.000598	0.00447	CcSEcCtD
Moclobemide—Osteoarthritis—Memantine—Alzheimer's disease	0.000598	0.00447	CcSEcCtD
Moclobemide—MAOA—embryo—Alzheimer's disease	0.000594	0.0529	CbGeAlD
Moclobemide—Osteoarthritis—Rivastigmine—Alzheimer's disease	0.000585	0.00437	CcSEcCtD
Moclobemide—Hallucination—Galantamine—Alzheimer's disease	0.000585	0.00437	CcSEcCtD
Moclobemide—Gastritis—Donepezil—Alzheimer's disease	0.000583	0.00435	CcSEcCtD
Moclobemide—Migraine—Rivastigmine—Alzheimer's disease	0.000576	0.0043	CcSEcCtD
Moclobemide—Abdominal distension—Donepezil—Alzheimer's disease	0.000573	0.00428	CcSEcCtD
Moclobemide—Haloperidol—GRIN2B—Alzheimer's disease	0.000572	0.139	CrCbGaD
Moclobemide—Irritability—Memantine—Alzheimer's disease	0.000571	0.00426	CcSEcCtD
Moclobemide—Visual impairment—Galantamine—Alzheimer's disease	0.000566	0.00423	CcSEcCtD
Moclobemide—MAOB—telencephalon—Alzheimer's disease	0.000566	0.0505	CbGeAlD
Moclobemide—Angina pectoris—Donepezil—Alzheimer's disease	0.000554	0.00414	CcSEcCtD
Moclobemide—Tinnitus—Galantamine—Alzheimer's disease	0.000548	0.00409	CcSEcCtD
Moclobemide—Dry skin—Memantine—Alzheimer's disease	0.000548	0.00409	CcSEcCtD
Moclobemide—Flushing—Galantamine—Alzheimer's disease	0.000546	0.00407	CcSEcCtD
Moclobemide—Dry skin—Rivastigmine—Alzheimer's disease	0.000536	0.004	CcSEcCtD
Moclobemide—Dysuria—Donepezil—Alzheimer's disease	0.000532	0.00397	CcSEcCtD
Moclobemide—Gastritis—Memantine—Alzheimer's disease	0.000529	0.00395	CcSEcCtD
Moclobemide—MAOA—forebrain—Alzheimer's disease	0.000525	0.0468	CbGeAlD
Moclobemide—Gastritis—Rivastigmine—Alzheimer's disease	0.000518	0.00387	CcSEcCtD
Moclobemide—Flatulence—Galantamine—Alzheimer's disease	0.000504	0.00377	CcSEcCtD
Moclobemide—Angina pectoris—Memantine—Alzheimer's disease	0.000503	0.00376	CcSEcCtD
Moclobemide—Tension—Galantamine—Alzheimer's disease	0.000502	0.00375	CcSEcCtD
Moclobemide—Dysgeusia—Galantamine—Alzheimer's disease	0.000501	0.00374	CcSEcCtD
Moclobemide—Nervousness—Galantamine—Alzheimer's disease	0.000497	0.00371	CcSEcCtD
Moclobemide—Conjunctivitis—Donepezil—Alzheimer's disease	0.000493	0.00368	CcSEcCtD
Moclobemide—Angina pectoris—Rivastigmine—Alzheimer's disease	0.000492	0.00368	CcSEcCtD
Moclobemide—Sweating—Donepezil—Alzheimer's disease	0.000486	0.00363	CcSEcCtD
Moclobemide—Dysuria—Memantine—Alzheimer's disease	0.000483	0.00361	CcSEcCtD
Moclobemide—MAOA—telencephalon—Alzheimer's disease	0.000483	0.0431	CbGeAlD
Moclobemide—Vision blurred—Galantamine—Alzheimer's disease	0.000482	0.0036	CcSEcCtD
Moclobemide—Tremor—Galantamine—Alzheimer's disease	0.000479	0.00358	CcSEcCtD
Moclobemide—Ill-defined disorder—Galantamine—Alzheimer's disease	0.000475	0.00355	CcSEcCtD
Moclobemide—Dysuria—Rivastigmine—Alzheimer's disease	0.000473	0.00353	CcSEcCtD
Moclobemide—Agitation—Galantamine—Alzheimer's disease	0.00047	0.00351	CcSEcCtD
Moclobemide—Bradycardia—Donepezil—Alzheimer's disease	0.000464	0.00346	CcSEcCtD
Moclobemide—Malaise—Galantamine—Alzheimer's disease	0.000461	0.00345	CcSEcCtD
Moclobemide—Syncope—Galantamine—Alzheimer's disease	0.000459	0.00343	CcSEcCtD
Moclobemide—Hallucination—Donepezil—Alzheimer's disease	0.000453	0.00338	CcSEcCtD
Moclobemide—Palpitations—Galantamine—Alzheimer's disease	0.000452	0.00338	CcSEcCtD
Moclobemide—Drowsiness—Rivastigmine—Alzheimer's disease	0.000451	0.00337	CcSEcCtD
Moclobemide—Loss of consciousness—Galantamine—Alzheimer's disease	0.00045	0.00336	CcSEcCtD
Moclobemide—Conjunctivitis—Memantine—Alzheimer's disease	0.000448	0.00334	CcSEcCtD
Moclobemide—Hypertension—Galantamine—Alzheimer's disease	0.000442	0.0033	CcSEcCtD
Moclobemide—Visual impairment—Donepezil—Alzheimer's disease	0.000439	0.00328	CcSEcCtD
Moclobemide—Conjunctivitis—Rivastigmine—Alzheimer's disease	0.000438	0.00327	CcSEcCtD
Moclobemide—Chest pain—Galantamine—Alzheimer's disease	0.000436	0.00325	CcSEcCtD
Moclobemide—Myalgia—Galantamine—Alzheimer's disease	0.000436	0.00325	CcSEcCtD
Moclobemide—Bezafibrate—PPARG—Alzheimer's disease	0.000436	0.106	CrCbGaD
Moclobemide—Anxiety—Galantamine—Alzheimer's disease	0.000434	0.00324	CcSEcCtD
Moclobemide—Sweating—Rivastigmine—Alzheimer's disease	0.000432	0.00323	CcSEcCtD
Moclobemide—Discomfort—Galantamine—Alzheimer's disease	0.00043	0.00321	CcSEcCtD
Moclobemide—Procainamide—ACHE—Alzheimer's disease	0.000427	0.104	CrCbGaD
Moclobemide—Minaprine—SLC6A4—Alzheimer's disease	0.000427	0.104	CrCbGaD
Moclobemide—Dry mouth—Galantamine—Alzheimer's disease	0.000426	0.00318	CcSEcCtD
Moclobemide—Tinnitus—Donepezil—Alzheimer's disease	0.000425	0.00317	CcSEcCtD
Moclobemide—Confusional state—Galantamine—Alzheimer's disease	0.000421	0.00314	CcSEcCtD
Moclobemide—Bradycardia—Memantine—Alzheimer's disease	0.000421	0.00314	CcSEcCtD
Moclobemide—Bradycardia—Rivastigmine—Alzheimer's disease	0.000412	0.00308	CcSEcCtD
Moclobemide—Hallucination—Memantine—Alzheimer's disease	0.000412	0.00307	CcSEcCtD
Moclobemide—Shock—Galantamine—Alzheimer's disease	0.000411	0.00307	CcSEcCtD
Moclobemide—Tachycardia—Galantamine—Alzheimer's disease	0.000408	0.00304	CcSEcCtD
Moclobemide—Hyperhidrosis—Galantamine—Alzheimer's disease	0.000404	0.00301	CcSEcCtD
Moclobemide—Hallucination—Rivastigmine—Alzheimer's disease	0.000403	0.00301	CcSEcCtD
Moclobemide—Visual impairment—Memantine—Alzheimer's disease	0.000399	0.00298	CcSEcCtD
Moclobemide—Flatulence—Donepezil—Alzheimer's disease	0.000391	0.00292	CcSEcCtD
Moclobemide—Hypotension—Galantamine—Alzheimer's disease	0.00039	0.00291	CcSEcCtD
Moclobemide—Visual impairment—Rivastigmine—Alzheimer's disease	0.00039	0.00291	CcSEcCtD
Moclobemide—Tension—Donepezil—Alzheimer's disease	0.000389	0.00291	CcSEcCtD
Moclobemide—Dysgeusia—Donepezil—Alzheimer's disease	0.000388	0.0029	CcSEcCtD
Moclobemide—Tinnitus—Memantine—Alzheimer's disease	0.000386	0.00288	CcSEcCtD
Moclobemide—Nervousness—Donepezil—Alzheimer's disease	0.000385	0.00288	CcSEcCtD
Moclobemide—Flushing—Memantine—Alzheimer's disease	0.000384	0.00287	CcSEcCtD
Moclobemide—Musculoskeletal discomfort—Galantamine—Alzheimer's disease	0.00038	0.00284	CcSEcCtD
Moclobemide—Insomnia—Galantamine—Alzheimer's disease	0.000378	0.00282	CcSEcCtD
Moclobemide—Tinnitus—Rivastigmine—Alzheimer's disease	0.000377	0.00282	CcSEcCtD
Moclobemide—Flushing—Rivastigmine—Alzheimer's disease	0.000376	0.0028	CcSEcCtD
Moclobemide—Paraesthesia—Galantamine—Alzheimer's disease	0.000375	0.0028	CcSEcCtD
Moclobemide—Vision blurred—Donepezil—Alzheimer's disease	0.000374	0.00279	CcSEcCtD
Moclobemide—Tremor—Donepezil—Alzheimer's disease	0.000372	0.00277	CcSEcCtD
Moclobemide—Somnolence—Galantamine—Alzheimer's disease	0.000371	0.00277	CcSEcCtD
Moclobemide—Ill-defined disorder—Donepezil—Alzheimer's disease	0.000368	0.00275	CcSEcCtD
Moclobemide—Dyspepsia—Galantamine—Alzheimer's disease	0.000368	0.00275	CcSEcCtD
Moclobemide—Agitation—Donepezil—Alzheimer's disease	0.000364	0.00272	CcSEcCtD
Moclobemide—Decreased appetite—Galantamine—Alzheimer's disease	0.000363	0.00271	CcSEcCtD
Moclobemide—Fatigue—Galantamine—Alzheimer's disease	0.00036	0.00269	CcSEcCtD
Moclobemide—Malaise—Donepezil—Alzheimer's disease	0.000358	0.00267	CcSEcCtD
Moclobemide—Constipation—Galantamine—Alzheimer's disease	0.000357	0.00267	CcSEcCtD
Moclobemide—Syncope—Donepezil—Alzheimer's disease	0.000356	0.00266	CcSEcCtD
Moclobemide—Flatulence—Memantine—Alzheimer's disease	0.000355	0.00265	CcSEcCtD
Moclobemide—Tension—Memantine—Alzheimer's disease	0.000353	0.00264	CcSEcCtD
Moclobemide—Dysgeusia—Memantine—Alzheimer's disease	0.000353	0.00263	CcSEcCtD
Moclobemide—Nervousness—Memantine—Alzheimer's disease	0.00035	0.00261	CcSEcCtD
Moclobemide—Loss of consciousness—Donepezil—Alzheimer's disease	0.000349	0.0026	CcSEcCtD
Moclobemide—Flatulence—Rivastigmine—Alzheimer's disease	0.000347	0.00259	CcSEcCtD
Moclobemide—Tension—Rivastigmine—Alzheimer's disease	0.000346	0.00258	CcSEcCtD
Moclobemide—Dysgeusia—Rivastigmine—Alzheimer's disease	0.000345	0.00258	CcSEcCtD
Moclobemide—Feeling abnormal—Galantamine—Alzheimer's disease	0.000344	0.00257	CcSEcCtD
Moclobemide—Hypertension—Donepezil—Alzheimer's disease	0.000342	0.00256	CcSEcCtD
Moclobemide—Nervousness—Rivastigmine—Alzheimer's disease	0.000342	0.00255	CcSEcCtD
Moclobemide—Gastrointestinal pain—Galantamine—Alzheimer's disease	0.000341	0.00255	CcSEcCtD
Moclobemide—Vision blurred—Memantine—Alzheimer's disease	0.000339	0.00253	CcSEcCtD
Moclobemide—Myalgia—Donepezil—Alzheimer's disease	0.000338	0.00252	CcSEcCtD
Moclobemide—Chest pain—Donepezil—Alzheimer's disease	0.000338	0.00252	CcSEcCtD
Moclobemide—Tremor—Memantine—Alzheimer's disease	0.000337	0.00252	CcSEcCtD
Moclobemide—Anxiety—Donepezil—Alzheimer's disease	0.000336	0.00251	CcSEcCtD
Moclobemide—Ill-defined disorder—Memantine—Alzheimer's disease	0.000334	0.00249	CcSEcCtD
Moclobemide—MAOB—nervous system—Alzheimer's disease	0.000334	0.0298	CbGeAlD
Moclobemide—Discomfort—Donepezil—Alzheimer's disease	0.000334	0.00249	CcSEcCtD
Moclobemide—Vision blurred—Rivastigmine—Alzheimer's disease	0.000332	0.00248	CcSEcCtD
Moclobemide—Agitation—Memantine—Alzheimer's disease	0.000331	0.00247	CcSEcCtD
Moclobemide—Dry mouth—Donepezil—Alzheimer's disease	0.00033	0.00247	CcSEcCtD
Moclobemide—Abdominal pain—Galantamine—Alzheimer's disease	0.00033	0.00247	CcSEcCtD
Moclobemide—Tremor—Rivastigmine—Alzheimer's disease	0.00033	0.00246	CcSEcCtD
Moclobemide—Minaprine—HTR2A—Alzheimer's disease	0.000328	0.0799	CrCbGaD
Moclobemide—Ill-defined disorder—Rivastigmine—Alzheimer's disease	0.000327	0.00244	CcSEcCtD
Moclobemide—Confusional state—Donepezil—Alzheimer's disease	0.000326	0.00244	CcSEcCtD
Moclobemide—Malaise—Memantine—Alzheimer's disease	0.000325	0.00242	CcSEcCtD
Moclobemide—Agitation—Rivastigmine—Alzheimer's disease	0.000324	0.00242	CcSEcCtD
Moclobemide—Syncope—Memantine—Alzheimer's disease	0.000323	0.00241	CcSEcCtD
Moclobemide—MAOB—central nervous system—Alzheimer's disease	0.000322	0.0287	CbGeAlD
Moclobemide—Shock—Donepezil—Alzheimer's disease	0.000318	0.00238	CcSEcCtD
Moclobemide—Palpitations—Memantine—Alzheimer's disease	0.000318	0.00238	CcSEcCtD
Moclobemide—Malaise—Rivastigmine—Alzheimer's disease	0.000318	0.00237	CcSEcCtD
Moclobemide—Loss of consciousness—Memantine—Alzheimer's disease	0.000316	0.00236	CcSEcCtD
Moclobemide—Syncope—Rivastigmine—Alzheimer's disease	0.000316	0.00236	CcSEcCtD
Moclobemide—MAOB—cerebellum—Alzheimer's disease	0.000314	0.028	CbGeAlD
Moclobemide—Hyperhidrosis—Donepezil—Alzheimer's disease	0.000313	0.00234	CcSEcCtD
Moclobemide—CYP2D6—forebrain—Alzheimer's disease	0.000312	0.0278	CbGeAlD
Moclobemide—Palpitations—Rivastigmine—Alzheimer's disease	0.000311	0.00232	CcSEcCtD
Moclobemide—Hypertension—Memantine—Alzheimer's disease	0.000311	0.00232	CcSEcCtD
Moclobemide—Loss of consciousness—Rivastigmine—Alzheimer's disease	0.00031	0.00231	CcSEcCtD
Moclobemide—Chest pain—Memantine—Alzheimer's disease	0.000307	0.00229	CcSEcCtD
Moclobemide—Myalgia—Memantine—Alzheimer's disease	0.000307	0.00229	CcSEcCtD
Moclobemide—Anxiety—Memantine—Alzheimer's disease	0.000305	0.00228	CcSEcCtD
Moclobemide—Hypertension—Rivastigmine—Alzheimer's disease	0.000304	0.00227	CcSEcCtD
Moclobemide—Discomfort—Memantine—Alzheimer's disease	0.000303	0.00226	CcSEcCtD
Moclobemide—Hypotension—Donepezil—Alzheimer's disease	0.000302	0.00226	CcSEcCtD
Moclobemide—Minaprine—CYP2D6—Alzheimer's disease	0.0003	0.0731	CrCbGaD
Moclobemide—Myalgia—Rivastigmine—Alzheimer's disease	0.0003	0.00224	CcSEcCtD
Moclobemide—Chest pain—Rivastigmine—Alzheimer's disease	0.0003	0.00224	CcSEcCtD
Moclobemide—Dry mouth—Memantine—Alzheimer's disease	0.0003	0.00224	CcSEcCtD
Moclobemide—Asthenia—Galantamine—Alzheimer's disease	0.0003	0.00224	CcSEcCtD
Moclobemide—Anxiety—Rivastigmine—Alzheimer's disease	0.000299	0.00223	CcSEcCtD
Moclobemide—Confusional state—Memantine—Alzheimer's disease	0.000296	0.00221	CcSEcCtD
Moclobemide—Discomfort—Rivastigmine—Alzheimer's disease	0.000296	0.00221	CcSEcCtD
Moclobemide—Musculoskeletal discomfort—Donepezil—Alzheimer's disease	0.000295	0.0022	CcSEcCtD
Moclobemide—Dry mouth—Rivastigmine—Alzheimer's disease	0.000293	0.00219	CcSEcCtD
Moclobemide—Insomnia—Donepezil—Alzheimer's disease	0.000293	0.00219	CcSEcCtD
Moclobemide—Paraesthesia—Donepezil—Alzheimer's disease	0.000291	0.00217	CcSEcCtD
Moclobemide—Confusional state—Rivastigmine—Alzheimer's disease	0.00029	0.00216	CcSEcCtD
Moclobemide—Shock—Memantine—Alzheimer's disease	0.000289	0.00216	CcSEcCtD
Moclobemide—Dyspnoea—Donepezil—Alzheimer's disease	0.000289	0.00215	CcSEcCtD
Moclobemide—Somnolence—Donepezil—Alzheimer's disease	0.000288	0.00215	CcSEcCtD
Moclobemide—CYP2D6—telencephalon—Alzheimer's disease	0.000287	0.0256	CbGeAlD
Moclobemide—Tachycardia—Memantine—Alzheimer's disease	0.000287	0.00214	CcSEcCtD
Moclobemide—Diarrhoea—Galantamine—Alzheimer's disease	0.000286	0.00213	CcSEcCtD
Moclobemide—MAOA—nervous system—Alzheimer's disease	0.000285	0.0254	CbGeAlD
Moclobemide—Dyspepsia—Donepezil—Alzheimer's disease	0.000285	0.00213	CcSEcCtD
Moclobemide—Hyperhidrosis—Memantine—Alzheimer's disease	0.000284	0.00212	CcSEcCtD
Moclobemide—Shock—Rivastigmine—Alzheimer's disease	0.000283	0.00211	CcSEcCtD
Moclobemide—Decreased appetite—Donepezil—Alzheimer's disease	0.000281	0.0021	CcSEcCtD
Moclobemide—Tachycardia—Rivastigmine—Alzheimer's disease	0.000281	0.0021	CcSEcCtD
Moclobemide—Fatigue—Donepezil—Alzheimer's disease	0.000279	0.00208	CcSEcCtD
Moclobemide—Hyperhidrosis—Rivastigmine—Alzheimer's disease	0.000278	0.00208	CcSEcCtD
Moclobemide—Constipation—Donepezil—Alzheimer's disease	0.000277	0.00207	CcSEcCtD
Moclobemide—Dizziness—Galantamine—Alzheimer's disease	0.000276	0.00206	CcSEcCtD
Moclobemide—Hypotension—Memantine—Alzheimer's disease	0.000275	0.00205	CcSEcCtD
Moclobemide—MAOA—central nervous system—Alzheimer's disease	0.000274	0.0245	CbGeAlD
Moclobemide—Hypotension—Rivastigmine—Alzheimer's disease	0.000269	0.00201	CcSEcCtD
Moclobemide—MAOA—cerebellum—Alzheimer's disease	0.000268	0.0239	CbGeAlD
Moclobemide—Musculoskeletal discomfort—Memantine—Alzheimer's disease	0.000268	0.002	CcSEcCtD
Moclobemide—Feeling abnormal—Donepezil—Alzheimer's disease	0.000267	0.00199	CcSEcCtD
Moclobemide—Insomnia—Memantine—Alzheimer's disease	0.000266	0.00198	CcSEcCtD
Moclobemide—Vomiting—Galantamine—Alzheimer's disease	0.000266	0.00198	CcSEcCtD
Moclobemide—Gastrointestinal pain—Donepezil—Alzheimer's disease	0.000265	0.00198	CcSEcCtD
Moclobemide—Paraesthesia—Memantine—Alzheimer's disease	0.000264	0.00197	CcSEcCtD
Moclobemide—Rash—Galantamine—Alzheimer's disease	0.000263	0.00197	CcSEcCtD
Moclobemide—Dermatitis—Galantamine—Alzheimer's disease	0.000263	0.00196	CcSEcCtD
Moclobemide—Dyspnoea—Memantine—Alzheimer's disease	0.000262	0.00196	CcSEcCtD
Moclobemide—Musculoskeletal discomfort—Rivastigmine—Alzheimer's disease	0.000262	0.00196	CcSEcCtD
Moclobemide—Headache—Galantamine—Alzheimer's disease	0.000262	0.00195	CcSEcCtD
Moclobemide—Somnolence—Memantine—Alzheimer's disease	0.000261	0.00195	CcSEcCtD
Moclobemide—Insomnia—Rivastigmine—Alzheimer's disease	0.00026	0.00194	CcSEcCtD
Moclobemide—Dyspepsia—Memantine—Alzheimer's disease	0.000259	0.00193	CcSEcCtD
Moclobemide—Paraesthesia—Rivastigmine—Alzheimer's disease	0.000258	0.00193	CcSEcCtD
Moclobemide—Urticaria—Donepezil—Alzheimer's disease	0.000257	0.00192	CcSEcCtD
Moclobemide—Dyspnoea—Rivastigmine—Alzheimer's disease	0.000256	0.00191	CcSEcCtD
Moclobemide—Abdominal pain—Donepezil—Alzheimer's disease	0.000256	0.00191	CcSEcCtD
Moclobemide—Somnolence—Rivastigmine—Alzheimer's disease	0.000256	0.00191	CcSEcCtD
Moclobemide—Decreased appetite—Memantine—Alzheimer's disease	0.000255	0.00191	CcSEcCtD
Moclobemide—MAOB—brain—Alzheimer's disease	0.000255	0.0228	CbGeAlD
Moclobemide—Fatigue—Memantine—Alzheimer's disease	0.000253	0.00189	CcSEcCtD
Moclobemide—Dyspepsia—Rivastigmine—Alzheimer's disease	0.000253	0.00189	CcSEcCtD
Moclobemide—Constipation—Memantine—Alzheimer's disease	0.000251	0.00188	CcSEcCtD
Moclobemide—Procainamide—BCHE—Alzheimer's disease	0.000251	0.0612	CrCbGaD
Moclobemide—Decreased appetite—Rivastigmine—Alzheimer's disease	0.00025	0.00187	CcSEcCtD
Moclobemide—Nausea—Galantamine—Alzheimer's disease	0.000248	0.00185	CcSEcCtD
Moclobemide—Fatigue—Rivastigmine—Alzheimer's disease	0.000248	0.00185	CcSEcCtD
Moclobemide—Constipation—Rivastigmine—Alzheimer's disease	0.000246	0.00184	CcSEcCtD
Moclobemide—Feeling abnormal—Memantine—Alzheimer's disease	0.000242	0.00181	CcSEcCtD
Moclobemide—Gastrointestinal pain—Memantine—Alzheimer's disease	0.00024	0.00179	CcSEcCtD
Moclobemide—Feeling abnormal—Rivastigmine—Alzheimer's disease	0.000237	0.00177	CcSEcCtD
Moclobemide—Gastrointestinal pain—Rivastigmine—Alzheimer's disease	0.000235	0.00176	CcSEcCtD
Moclobemide—Urticaria—Memantine—Alzheimer's disease	0.000233	0.00174	CcSEcCtD
Moclobemide—Abdominal pain—Memantine—Alzheimer's disease	0.000232	0.00173	CcSEcCtD
Moclobemide—Asthenia—Donepezil—Alzheimer's disease	0.000232	0.00173	CcSEcCtD
Moclobemide—Pruritus—Donepezil—Alzheimer's disease	0.000229	0.00171	CcSEcCtD
Moclobemide—Urticaria—Rivastigmine—Alzheimer's disease	0.000228	0.00171	CcSEcCtD
Moclobemide—Abdominal pain—Rivastigmine—Alzheimer's disease	0.000227	0.0017	CcSEcCtD
Moclobemide—Diarrhoea—Donepezil—Alzheimer's disease	0.000221	0.00165	CcSEcCtD
Moclobemide—MAOA—brain—Alzheimer's disease	0.000218	0.0194	CbGeAlD
Moclobemide—Dizziness—Donepezil—Alzheimer's disease	0.000214	0.0016	CcSEcCtD
Moclobemide—Asthenia—Memantine—Alzheimer's disease	0.000211	0.00157	CcSEcCtD
Moclobemide—Pruritus—Memantine—Alzheimer's disease	0.000208	0.00155	CcSEcCtD
Moclobemide—Asthenia—Rivastigmine—Alzheimer's disease	0.000206	0.00154	CcSEcCtD
Moclobemide—Vomiting—Donepezil—Alzheimer's disease	0.000206	0.00154	CcSEcCtD
Moclobemide—Rash—Donepezil—Alzheimer's disease	0.000204	0.00152	CcSEcCtD
Moclobemide—Dermatitis—Donepezil—Alzheimer's disease	0.000204	0.00152	CcSEcCtD
Moclobemide—Pruritus—Rivastigmine—Alzheimer's disease	0.000203	0.00152	CcSEcCtD
Moclobemide—Headache—Donepezil—Alzheimer's disease	0.000203	0.00151	CcSEcCtD
Moclobemide—Diarrhoea—Memantine—Alzheimer's disease	0.000201	0.0015	CcSEcCtD
Moclobemide—Diarrhoea—Rivastigmine—Alzheimer's disease	0.000197	0.00147	CcSEcCtD
Moclobemide—Dizziness—Memantine—Alzheimer's disease	0.000194	0.00145	CcSEcCtD
Moclobemide—Nausea—Donepezil—Alzheimer's disease	0.000192	0.00144	CcSEcCtD
Moclobemide—Dizziness—Rivastigmine—Alzheimer's disease	0.00019	0.00142	CcSEcCtD
Moclobemide—Vomiting—Memantine—Alzheimer's disease	0.000187	0.0014	CcSEcCtD
Moclobemide—Rash—Memantine—Alzheimer's disease	0.000185	0.00138	CcSEcCtD
Moclobemide—Dermatitis—Memantine—Alzheimer's disease	0.000185	0.00138	CcSEcCtD
Moclobemide—Headache—Memantine—Alzheimer's disease	0.000184	0.00137	CcSEcCtD
Moclobemide—Vomiting—Rivastigmine—Alzheimer's disease	0.000183	0.00137	CcSEcCtD
Moclobemide—Rash—Rivastigmine—Alzheimer's disease	0.000181	0.00135	CcSEcCtD
Moclobemide—Dermatitis—Rivastigmine—Alzheimer's disease	0.000181	0.00135	CcSEcCtD
Moclobemide—Headache—Rivastigmine—Alzheimer's disease	0.00018	0.00134	CcSEcCtD
Moclobemide—Nausea—Memantine—Alzheimer's disease	0.000175	0.0013	CcSEcCtD
Moclobemide—Nausea—Rivastigmine—Alzheimer's disease	0.000171	0.00128	CcSEcCtD
Moclobemide—CYP2D6—nervous system—Alzheimer's disease	0.000169	0.0151	CbGeAlD
Moclobemide—CYP2D6—central nervous system—Alzheimer's disease	0.000163	0.0145	CbGeAlD
Moclobemide—CYP2D6—cerebellum—Alzheimer's disease	0.000159	0.0142	CbGeAlD
Moclobemide—Haloperidol—HTR2A—Alzheimer's disease	0.000155	0.0378	CrCbGaD
Moclobemide—Haloperidol—CYP2D6—Alzheimer's disease	0.000142	0.0346	CrCbGaD
Moclobemide—Procainamide—CYP2D6—Alzheimer's disease	0.000138	0.0336	CrCbGaD
Moclobemide—CYP2D6—brain—Alzheimer's disease	0.000129	0.0115	CbGeAlD
Moclobemide—CYP2C9—Biological oxidations—PTGS1—Alzheimer's disease	4.51e-05	0.000815	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—ATP5A1—Alzheimer's disease	4.49e-05	0.000811	CbGpPWpGaD
Moclobemide—MAOA—Transmission across Chemical Synapses—CREB1—Alzheimer's disease	4.45e-05	0.000804	CbGpPWpGaD
Moclobemide—CYP2C9—Biological oxidations—CYP2D6—Alzheimer's disease	4.43e-05	0.0008	CbGpPWpGaD
Moclobemide—CYP2C9—Metapathway biotransformation—CYP2D6—Alzheimer's disease	4.37e-05	0.000789	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—PLD3—Alzheimer's disease	4.29e-05	0.000774	CbGpPWpGaD
Moclobemide—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—Alzheimer's disease	4.25e-05	0.000767	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism of lipids and lipoproteins—CYP46A1—Alzheimer's disease	4.2e-05	0.000759	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism of lipids and lipoproteins—PLD3—Alzheimer's disease	4.15e-05	0.00075	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—HSD17B10—Alzheimer's disease	4.11e-05	0.000742	CbGpPWpGaD
Moclobemide—MAOA—SIDS Susceptibility Pathways—IL1B—Alzheimer's disease	4.03e-05	0.000728	CbGpPWpGaD
Moclobemide—MAOA—SIDS Susceptibility Pathways—CASP3—Alzheimer's disease	4.02e-05	0.000727	CbGpPWpGaD
Moclobemide—MAOA—Neuronal System—CALM1—Alzheimer's disease	3.99e-05	0.00072	CbGpPWpGaD
Moclobemide—CYP1A2—Arachidonic acid metabolism—PTGS2—Alzheimer's disease	3.97e-05	0.000717	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—CYP46A1—Alzheimer's disease	3.96e-05	0.000714	CbGpPWpGaD
Moclobemide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—Alzheimer's disease	3.95e-05	0.000713	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—TPI1—Alzheimer's disease	3.92e-05	0.000709	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—CHAT—Alzheimer's disease	3.92e-05	0.000709	CbGpPWpGaD
Moclobemide—CYP1A2—Biological oxidations—PTGS1—Alzheimer's disease	3.86e-05	0.000697	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism of lipids and lipoproteins—CYP46A1—Alzheimer's disease	3.83e-05	0.000692	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—ND1—Alzheimer's disease	3.82e-05	0.00069	CbGpPWpGaD
Moclobemide—CYP1A2—Biological oxidations—CYP2D6—Alzheimer's disease	3.78e-05	0.000683	CbGpPWpGaD
Moclobemide—CYP1A2—Metapathway biotransformation—CYP2D6—Alzheimer's disease	3.73e-05	0.000674	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—GAPDH—Alzheimer's disease	3.62e-05	0.000654	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism of lipids and lipoproteins—PLD3—Alzheimer's disease	3.55e-05	0.000641	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—A2M—Alzheimer's disease	3.5e-05	0.000632	CbGpPWpGaD
Moclobemide—MAOA—SIDS Susceptibility Pathways—VEGFA—Alzheimer's disease	3.41e-05	0.000617	CbGpPWpGaD
Moclobemide—MAOA—Neuronal System—CREB1—Alzheimer's disease	3.41e-05	0.000616	CbGpPWpGaD
Moclobemide—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—Alzheimer's disease	3.34e-05	0.000604	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism of lipids and lipoproteins—CYP46A1—Alzheimer's disease	3.28e-05	0.000592	CbGpPWpGaD
Moclobemide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—Alzheimer's disease	3.07e-05	0.000554	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—ACHE—Alzheimer's disease	3.04e-05	0.000549	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—INPP5D—Alzheimer's disease	3.01e-05	0.000543	CbGpPWpGaD
Moclobemide—MAOA—SIDS Susceptibility Pathways—TNF—Alzheimer's disease	2.93e-05	0.000528	CbGpPWpGaD
Moclobemide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—Alzheimer's disease	2.87e-05	0.000518	CbGpPWpGaD
Moclobemide—CYP1A2—Aryl Hydrocarbon Receptor—TNF—Alzheimer's disease	2.87e-05	0.000518	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—PTGS1—Alzheimer's disease	2.85e-05	0.000515	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—ENO1—Alzheimer's disease	2.85e-05	0.000515	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—DHCR24—Alzheimer's disease	2.81e-05	0.000507	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—CYP2D6—Alzheimer's disease	2.8e-05	0.000505	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—BCHE—Alzheimer's disease	2.65e-05	0.000479	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism of lipids and lipoproteins—CHAT—Alzheimer's disease	2.62e-05	0.000473	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—DHCR24—Alzheimer's disease	2.58e-05	0.000466	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—DHCR24—Alzheimer's disease	2.56e-05	0.000462	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—PLCB1—Alzheimer's disease	2.5e-05	0.000452	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—TPI1—Alzheimer's disease	2.46e-05	0.000445	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—CHAT—Alzheimer's disease	2.46e-05	0.000445	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—ABCA1—Alzheimer's disease	2.42e-05	0.000438	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—CA4—Alzheimer's disease	2.39e-05	0.000431	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism of lipids and lipoproteins—CHAT—Alzheimer's disease	2.39e-05	0.000431	CbGpPWpGaD
Moclobemide—MAOA—SIDS Susceptibility Pathways—IL6—Alzheimer's disease	2.36e-05	0.000426	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—MAOB—Alzheimer's disease	2.36e-05	0.000426	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism of lipids and lipoproteins—A2M—Alzheimer's disease	2.33e-05	0.000421	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—GAPDH—Alzheimer's disease	2.27e-05	0.00041	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—GAPDHS—Alzheimer's disease	2.24e-05	0.000405	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—CA4—Alzheimer's disease	2.19e-05	0.000396	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—A2M—Alzheimer's disease	2.19e-05	0.000396	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—DHCR24—Alzheimer's disease	2.19e-05	0.000395	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—CA4—Alzheimer's disease	2.18e-05	0.000393	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—ATP5A1—Alzheimer's disease	2.13e-05	0.000384	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism of lipids and lipoproteins—A2M—Alzheimer's disease	2.13e-05	0.000384	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—PPARGC1A—Alzheimer's disease	2.09e-05	0.000377	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—HMOX1—Alzheimer's disease	2.08e-05	0.000376	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—GAPDHS—Alzheimer's disease	2.06e-05	0.000373	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—GAPDHS—Alzheimer's disease	2.05e-05	0.000369	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism of lipids and lipoproteins—CHAT—Alzheimer's disease	2.04e-05	0.000368	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—PLD3—Alzheimer's disease	2.03e-05	0.000366	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism of lipids and lipoproteins—ACHE—Alzheimer's disease	2.03e-05	0.000366	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism of lipids and lipoproteins—INPP5D—Alzheimer's disease	2.01e-05	0.000362	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—ATP5A1—Alzheimer's disease	1.96e-05	0.000353	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—HSD17B10—Alzheimer's disease	1.95e-05	0.000351	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—ATP5A1—Alzheimer's disease	1.94e-05	0.00035	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—ACHE—Alzheimer's disease	1.91e-05	0.000345	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—LPL—Alzheimer's disease	1.9e-05	0.000344	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS1—Alzheimer's disease	1.9e-05	0.000343	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—INPP5D—Alzheimer's disease	1.89e-05	0.000341	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—CYP46A1—Alzheimer's disease	1.87e-05	0.000338	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—PLD3—Alzheimer's disease	1.87e-05	0.000337	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—CA4—Alzheimer's disease	1.86e-05	0.000336	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—PLD3—Alzheimer's disease	1.85e-05	0.000334	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism of lipids and lipoproteins—ACHE—Alzheimer's disease	1.85e-05	0.000334	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism of lipids and lipoproteins—INPP5D—Alzheimer's disease	1.83e-05	0.00033	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism of lipids and lipoproteins—A2M—Alzheimer's disease	1.82e-05	0.000328	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—ND1—Alzheimer's disease	1.81e-05	0.000327	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—HSD17B10—Alzheimer's disease	1.79e-05	0.000323	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—PTGS1—Alzheimer's disease	1.79e-05	0.000323	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—ENO1—Alzheimer's disease	1.79e-05	0.000323	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—HSD17B10—Alzheimer's disease	1.77e-05	0.00032	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—Alzheimer's disease	1.77e-05	0.000319	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—CYP2D6—Alzheimer's disease	1.75e-05	0.000317	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—GAPDHS—Alzheimer's disease	1.75e-05	0.000316	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—Alzheimer's disease	1.73e-05	0.000313	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—CYP46A1—Alzheimer's disease	1.72e-05	0.000311	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—MTHFR—Alzheimer's disease	1.71e-05	0.000309	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—CYP46A1—Alzheimer's disease	1.71e-05	0.000308	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—ND1—Alzheimer's disease	1.66e-05	0.0003	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—BCHE—Alzheimer's disease	1.66e-05	0.0003	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—ATP5A1—Alzheimer's disease	1.66e-05	0.000299	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—ND1—Alzheimer's disease	1.65e-05	0.000298	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism of lipids and lipoproteins—ABCA1—Alzheimer's disease	1.62e-05	0.000292	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—Alzheimer's disease	1.61e-05	0.000291	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—CALM1—Alzheimer's disease	1.6e-05	0.000289	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—APOE—Alzheimer's disease	1.59e-05	0.000288	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—PLD3—Alzheimer's disease	1.58e-05	0.000286	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism of lipids and lipoproteins—ACHE—Alzheimer's disease	1.58e-05	0.000286	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—CAV1—Alzheimer's disease	1.58e-05	0.000285	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—PLCB1—Alzheimer's disease	1.57e-05	0.000283	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism of lipids and lipoproteins—INPP5D—Alzheimer's disease	1.56e-05	0.000282	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—ABCA1—Alzheimer's disease	1.52e-05	0.000275	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—HSD17B10—Alzheimer's disease	1.52e-05	0.000274	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—Alzheimer's disease	1.48e-05	0.000268	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism of lipids and lipoproteins—ABCA1—Alzheimer's disease	1.47e-05	0.000266	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—CYP46A1—Alzheimer's disease	1.46e-05	0.000263	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—ND1—Alzheimer's disease	1.41e-05	0.000254	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism of lipids and lipoproteins—PPARGC1A—Alzheimer's disease	1.39e-05	0.000252	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—PPARG—Alzheimer's disease	1.39e-05	0.000251	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—Alzheimer's disease	1.38e-05	0.000249	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—INS—Alzheimer's disease	1.36e-05	0.000246	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—PPARGC1A—Alzheimer's disease	1.31e-05	0.000237	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—HMOX1—Alzheimer's disease	1.3e-05	0.000236	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism of lipids and lipoproteins—PPARGC1A—Alzheimer's disease	1.27e-05	0.000229	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	1.27e-05	0.000229	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism of lipids and lipoproteins—ABCA1—Alzheimer's disease	1.26e-05	0.000227	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—NOS3—Alzheimer's disease	1.19e-05	0.000216	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—LPL—Alzheimer's disease	1.19e-05	0.000216	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—CHAT—Alzheimer's disease	1.17e-05	0.00021	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—TPI1—Alzheimer's disease	1.17e-05	0.00021	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	1.16e-05	0.000209	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—MAOB—Alzheimer's disease	1.12e-05	0.000202	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—PTGS2—Alzheimer's disease	1.09e-05	0.000197	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism of lipids and lipoproteins—PPARGC1A—Alzheimer's disease	1.09e-05	0.000196	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—GAPDH—Alzheimer's disease	1.08e-05	0.000194	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—MTHFR—Alzheimer's disease	1.07e-05	0.000194	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—TPI1—Alzheimer's disease	1.07e-05	0.000194	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—CHAT—Alzheimer's disease	1.07e-05	0.000194	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	1.06e-05	0.000192	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—TPI1—Alzheimer's disease	1.06e-05	0.000192	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—CHAT—Alzheimer's disease	1.06e-05	0.000192	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	1.05e-05	0.00019	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—A2M—Alzheimer's disease	1.04e-05	0.000188	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—MAOB—Alzheimer's disease	1.03e-05	0.000186	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—MAOB—Alzheimer's disease	1.02e-05	0.000184	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—CALM1—Alzheimer's disease	1e-05	0.000181	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—APOE—Alzheimer's disease	1e-05	0.000181	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—CAV1—Alzheimer's disease	9.91e-06	0.000179	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—GAPDH—Alzheimer's disease	9.89e-06	0.000179	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	9.88e-06	0.000179	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—GAPDH—Alzheimer's disease	9.81e-06	0.000177	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	9.69e-06	0.000175	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	9.61e-06	0.000173	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—A2M—Alzheimer's disease	9.55e-06	0.000173	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—A2M—Alzheimer's disease	9.47e-06	0.000171	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	9.26e-06	0.000167	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—CHAT—Alzheimer's disease	9.08e-06	0.000164	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—TPI1—Alzheimer's disease	9.08e-06	0.000164	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—ACHE—Alzheimer's disease	9.04e-06	0.000163	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—INPP5D—Alzheimer's disease	8.93e-06	0.000161	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—PPARG—Alzheimer's disease	8.71e-06	0.000157	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—MAOB—Alzheimer's disease	8.7e-06	0.000157	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—INS—Alzheimer's disease	8.55e-06	0.000154	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—ENO1—Alzheimer's disease	8.47e-06	0.000153	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—PTGS1—Alzheimer's disease	8.47e-06	0.000153	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	8.44e-06	0.000153	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—GAPDH—Alzheimer's disease	8.38e-06	0.000151	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—ACHE—Alzheimer's disease	8.31e-06	0.00015	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—CYP2D6—Alzheimer's disease	8.3e-06	0.00015	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	8.28e-06	0.00015	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—ACHE—Alzheimer's disease	8.24e-06	0.000149	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—INPP5D—Alzheimer's disease	8.21e-06	0.000148	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	8.21e-06	0.000148	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—INPP5D—Alzheimer's disease	8.14e-06	0.000147	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—A2M—Alzheimer's disease	8.09e-06	0.000146	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—BCHE—Alzheimer's disease	7.87e-06	0.000142	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—ENO1—Alzheimer's disease	7.79e-06	0.000141	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—PTGS1—Alzheimer's disease	7.79e-06	0.000141	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—PTGS1—Alzheimer's disease	7.72e-06	0.000139	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—ENO1—Alzheimer's disease	7.72e-06	0.000139	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—CYP2D6—Alzheimer's disease	7.57e-06	0.000137	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—NOS3—Alzheimer's disease	7.49e-06	0.000135	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—PLCB1—Alzheimer's disease	7.43e-06	0.000134	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	7.29e-06	0.000132	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—BCHE—Alzheimer's disease	7.24e-06	0.000131	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	7.22e-06	0.00013	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—ABCA1—Alzheimer's disease	7.2e-06	0.00013	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—BCHE—Alzheimer's disease	7.18e-06	0.00013	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—ACHE—Alzheimer's disease	7.04e-06	0.000127	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—INPP5D—Alzheimer's disease	6.96e-06	0.000126	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—PTGS2—Alzheimer's disease	6.85e-06	0.000124	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—PLCB1—Alzheimer's disease	6.83e-06	0.000123	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—PLCB1—Alzheimer's disease	6.77e-06	0.000122	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	6.64e-06	0.00012	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—ABCA1—Alzheimer's disease	6.62e-06	0.00012	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—PTGS1—Alzheimer's disease	6.6e-06	0.000119	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—ENO1—Alzheimer's disease	6.6e-06	0.000119	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—ABCA1—Alzheimer's disease	6.56e-06	0.000119	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—CYP2D6—Alzheimer's disease	6.47e-06	0.000117	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—PPARGC1A—Alzheimer's disease	6.2e-06	0.000112	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—HMOX1—Alzheimer's disease	6.18e-06	0.000112	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—BCHE—Alzheimer's disease	6.13e-06	0.000111	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—PLCB1—Alzheimer's disease	5.79e-06	0.000105	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—PPARGC1A—Alzheimer's disease	5.71e-06	0.000103	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—HMOX1—Alzheimer's disease	5.68e-06	0.000103	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	5.68e-06	0.000103	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—PPARGC1A—Alzheimer's disease	5.66e-06	0.000102	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—LPL—Alzheimer's disease	5.65e-06	0.000102	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—HMOX1—Alzheimer's disease	5.63e-06	0.000102	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—ABCA1—Alzheimer's disease	5.61e-06	0.000101	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—AKT1—Alzheimer's disease	5.49e-06	9.92e-05	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—LPL—Alzheimer's disease	5.2e-06	9.38e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—LPL—Alzheimer's disease	5.15e-06	9.3e-05	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—MTHFR—Alzheimer's disease	5.09e-06	9.19e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—PPARGC1A—Alzheimer's disease	4.83e-06	8.73e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—HMOX1—Alzheimer's disease	4.81e-06	8.69e-05	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—CALM1—Alzheimer's disease	4.75e-06	8.58e-05	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—APOE—Alzheimer's disease	4.74e-06	8.55e-05	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—CAV1—Alzheimer's disease	4.69e-06	8.47e-05	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—MTHFR—Alzheimer's disease	4.68e-06	8.45e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—MTHFR—Alzheimer's disease	4.64e-06	8.38e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—LPL—Alzheimer's disease	4.4e-06	7.95e-05	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—CALM1—Alzheimer's disease	4.37e-06	7.89e-05	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—APOE—Alzheimer's disease	4.36e-06	7.87e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—CALM1—Alzheimer's disease	4.33e-06	7.83e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—APOE—Alzheimer's disease	4.32e-06	7.8e-05	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—CAV1—Alzheimer's disease	4.32e-06	7.79e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—CAV1—Alzheimer's disease	4.28e-06	7.73e-05	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—PPARG—Alzheimer's disease	4.12e-06	7.45e-05	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—INS—Alzheimer's disease	4.05e-06	7.31e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—MTHFR—Alzheimer's disease	3.96e-06	7.16e-05	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—PPARG—Alzheimer's disease	3.79e-06	6.85e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—PPARG—Alzheimer's disease	3.76e-06	6.79e-05	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—INS—Alzheimer's disease	3.72e-06	6.72e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—CALM1—Alzheimer's disease	3.7e-06	6.69e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—APOE—Alzheimer's disease	3.69e-06	6.66e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—INS—Alzheimer's disease	3.69e-06	6.66e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—CAV1—Alzheimer's disease	3.66e-06	6.6e-05	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—NOS3—Alzheimer's disease	3.55e-06	6.41e-05	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—AKT1—Alzheimer's disease	3.45e-06	6.22e-05	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—NOS3—Alzheimer's disease	3.26e-06	5.89e-05	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—PTGS2—Alzheimer's disease	3.24e-06	5.86e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—NOS3—Alzheimer's disease	3.23e-06	5.84e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—PPARG—Alzheimer's disease	3.21e-06	5.8e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—INS—Alzheimer's disease	3.15e-06	5.69e-05	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—PTGS2—Alzheimer's disease	2.98e-06	5.39e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—PTGS2—Alzheimer's disease	2.96e-06	5.34e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—NOS3—Alzheimer's disease	2.76e-06	4.99e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—PTGS2—Alzheimer's disease	2.53e-06	4.57e-05	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—AKT1—Alzheimer's disease	1.63e-06	2.95e-05	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—AKT1—Alzheimer's disease	1.5e-06	2.71e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—AKT1—Alzheimer's disease	1.49e-06	2.69e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—AKT1—Alzheimer's disease	1.27e-06	2.29e-05	CbGpPWpGaD
